
The IMFINZI Patient Savings Program is available to assist eligible, commercially insured patients with out-of-pocket costs for IMFINZI. There are no income requirements to participate.
Eligible patients with commercial insurance:
For more information, please visit azpatientsupport.com
*To be eligible, patients must be a resident of the United States or Puerto Rico and have commercial health insurance that covers medication costs for IMFINZI, but not the full cost to the patient. Patients are ineligible if prescriptions are paid by any state or other federally funded programs, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA or TRICARE, or where prohibited by law. Additional restrictions may apply. The IMFINZI Patient Savings Program covers the cost of IMFINZI and up to $100 administration cost per infusion, per drug, and does not cover costs for office visits, or any other associated costs. Offer is invalid for claims and transactions more than 365 days from the date of service. Individual costs and benefit design may vary by plan. Costs to patients may vary by plan. Please consult with individual plan for specific information.
†Patients who are residents of Massachusetts and Rhode Island are not eligible for infusion administration assistance. Patients are responsible for any cost associated with the infusion above the $100 per infusion assistance provided by the program.
The Access 360 program can help. We can answer questions about:
To learn more about the Access 360 program, please call 1-844-ASK-A360 (1-844-275-2360) Monday–Friday, 8 AM–6 PM ET or visit www.MyAccess360.com
To learn more about the Access 360 program, please call 1-844-ASK-A360 (1-844-275-2360) Monday–Friday, 8 AM–6 PM ET or visit www.MyAccess360.com
Explore Access 360The IMFINZI Patient Savings Program is available to assist with out-of-pocket costs for IMFINZI for eligible commercially insured patients. For more information, please visit astrazenecaspecialtysavings.com.
The IMFINZI Patient Savings Program is available to assist with out-of-pocket costs for IMFINZI for eligible commercially insured patients. For more information, please visit www.astrazenecaspecialtysavings.com.
Find specialists in your area
Use this HealthgradesTM tool to easily find nearby specialists with experience in treating gallbladder and/or bile duct cancer.
AstraZeneca does not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
*Gemcitabine and cisplatin.
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
IMFINZI is a prescription medicine used to treat adults with a type of cancer called biliary tract cancer (BTC), including cancer of the bile ducts (cholangiocarcinoma) and gallbladder cancer. IMFINZI may be used in combination with chemotherapy medicines gemcitabine and cisplatin when your BTC has spread to nearby tissues (locally advanced), or has spread to other parts of the body (metastatic).
It is not known if IMFINZI is safe and effective in children.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI if you have severe side effects
Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you:
Females who are able to become pregnant:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of IMFINZI when used with other anticancer medicines in people with BTC include feeling tired, nausea, constipation, decreased appetite, stomach (abdominal) pain, rash, and fever.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
IMFINZI is a prescription medicine used to treat adults with a type of cancer called biliary tract cancer (BTC), including cancer of the bile ducts (cholangiocarcinoma) and gallbladder cancer. IMFINZI may be used in combination with chemotherapy medicines gemcitabine and cisplatin when your BTC has spread to nearby tissues (locally advanced), or has spread to other parts of the body (metastatic).
It is not known if IMFINZI is safe and effective in children.
Please see Full Prescribing Information including Medication Guide for IMFINZI.
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune...
IMFINZI is a medicine that may treat...
IMFINZI is a prescription medicine used to treat adults with a type of cancer called biliary tract cancer (BTC), including cancer of the bile ducts (cholangiocarcinoma) and gallbladder cancer. IMFINZI may be used...
IMFINZI is a medicine that may treat certain cancers by work...
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to...